Invacare reported interim Q4 revenues of $181 million, +6% Y/Y, with growth in all regions and all major product categories. Gross margins improved by 310 basis points to 26.6%.

Invacare (IVC) delivered earnings and revenue surprises of -45.95% and 13.93%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Business Invacare files for bankruptcy protection, says it has plans to move forward Updated: Mar. 07, 2023, 10:12 a.m. | Published: Feb. 01, 2023, 4:20 p.m.

The next step in the drive by medical equipment maker Invacare Corp. (NYSE: IVC) to transform its operations involves discontinuing the production of respiratory products. Elyria-based Invacare, late ...